These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24140444)

  • 1. Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease.
    Prati F; Bartolini M; Simoni E; De Simone A; Pinto A; Andrisano V; Bolognesi ML
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6254-8. PubMed ID: 24140444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
    Bolognesi ML; Banzi R; Bartolini M; Cavalli A; Tarozzi A; Andrisano V; Minarini A; Rosini M; Tumiatti V; Bergamini C; Fato R; Lenaz G; Hrelia P; Cattaneo A; Recanatini M; Melchiorre C
    J Med Chem; 2007 Oct; 50(20):4882-97. PubMed ID: 17850125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
    Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D
    Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.
    Bolognesi ML; Bartolini M; Tarozzi A; Morroni F; Lizzi F; Milelli A; Minarini A; Rosini M; Hrelia P; Andrisano V; Melchiorre C
    Bioorg Med Chem Lett; 2011 May; 21(9):2655-8. PubMed ID: 21236667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
    Tang H; Zhao LZ; Zhao HT; Huang SL; Zhong SM; Qin JK; Chen ZF; Huang ZS; Liang H
    Eur J Med Chem; 2011 Oct; 46(10):4970-9. PubMed ID: 21871694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
    Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
    Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
    Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.
    Li Y; Peng P; Tang L; Hu Y; Hu Y; Sheng R
    Bioorg Med Chem; 2014 Sep; 22(17):4717-25. PubMed ID: 25082512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
    Rosini M; Simoni E; Bartolini M; Tarozzi A; Matera R; Milelli A; Hrelia P; Andrisano V; Bolognesi ML; Melchiorre C
    Eur J Med Chem; 2011 Nov; 46(11):5435-42. PubMed ID: 21924801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
    Pérez-Areales FJ; Di Pietro O; Espargaró A; Vallverdú-Queralt A; Galdeano C; Ragusa IM; Viayna E; Guillou C; Clos MV; Pérez B; Sabaté R; Lamuela-Raventós RM; Luque FJ; Muñoz-Torrero D
    Bioorg Med Chem; 2014 Oct; 22(19):5298-307. PubMed ID: 25156301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation.
    Tonelli M; Catto M; Tasso B; Novelli F; Canu C; Iusco G; Pisani L; Stradis AD; Denora N; Sparatore A; Boido V; Carotti A; Sparatore F
    ChemMedChem; 2015 Jun; 10(6):1040-53. PubMed ID: 25924599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
    Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
    Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action.
    Bolognesi ML; Bartolini M; Rosini M; Andrisano V; Melchiorre C
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4312-5. PubMed ID: 19505825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
    Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
    Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
    Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease.
    Dias KS; de Paula CT; Dos Santos T; Souza IN; Boni MS; Guimarães MJ; da Silva FM; Castro NG; Neves GA; Veloso CC; Coelho MM; de Melo IS; Giusti FC; Giusti-Paiva A; da Silva ML; Dardenne LE; Guedes IA; Pruccoli L; Morroni F; Tarozzi A; Viegas C
    Eur J Med Chem; 2017 Apr; 130():440-457. PubMed ID: 28282613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.